ERCC1 and non-small-cell lung cancer [8]

New England Journal of Medicine

Volumn 356, Issue 24, 2007, Pages 2538-2541

  Niedernhofer, Laura J ^a   Bhagwat, Nikhil ^a   Wood, Richard D ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 8F1; NUCLEASE; NUCLEIC ACID BINDING PROTEIN; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP F PROTEIN;

CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; DNA DAMAGE; DNA REPAIR; FIBROBLAST; GENE MUTATION; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LETTER; LUNG NON SMALL CELL CANCER; MOLECULAR WEIGHT; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SENSITIVITY AND SPECIFICITY; ULTRAVIOLET RADIATION;

EID: 34250333804     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/nejmc070742     Document Type: Letter

References (5)

1. Zheng Z, Chen T, Li X, Haura E, Sharma A, Bepler G. DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer. N Engl J Med 2007;356:800-8.
2. Sijbers AM, de Laat WL, Ariza RR, et al. Xeroderma pigmentosum group F caused by a defect in a structure-specific DNA repair endonuclease. Cell 1996;86:811-22.
3. Olaussen KA, Dunant A, Fouret P, et al. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med 2006;355:983-91.
4. Jaspers NG, Raams A, Silengo MC, et al. First reported patient with human ERCC1 deficiency has cerebro-oculo-facioskeletal syndrome with a mild defect in nucleotide excision repair and severe developmental failure. Am J Hum Genet 2007;80:457-66.
5. Volker M, Mone MJ, Karmakar P, et al. Sequential assembly of the nucleotide excision repair factors in vivo. Mol Cell 2001; 8:213-24.